Shares of Thermo Fisher Scientific Inc. TMO shed 1.04% to $528.87 Wednesday, on what proved to be an all-around great trading ...

Health care stocks have underperformed in recent months on uncertainty surrounding the incoming Donald Trump administration, but they can often be a solid defensive play in an uncertain economy.

Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...

As the global energy landscape evolves towards renewable sources, electric utilities and power plant operators are ...

The murder of UnitedHealthcare chief executive Brian Thompson in Manhattan on Wednesday has raised questions about security ...

This article from Thermo Scientific Data Visualization Solutions explains how Amira Software was able to solve a 60-year ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, announced today that it will be participating in the iAccess Alpha ...

Consistent data across subgroups underscore the potential of PrimeC to redefine the standard of care in the treatment of ALS CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 ...

Thermo Fisher Scientific (NYSE:TMO) has completed the repurchase of $1B (1.9M shares) of its common stock. As of Dec. 3, 2024, $3B remained available under the company’s share repurchase authorization ...

Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under ...